DK522885A - Skaansomme beta-adrenerge blokerende midler - Google Patents

Skaansomme beta-adrenerge blokerende midler Download PDF

Info

Publication number
DK522885A
DK522885A DK522885A DK522885A DK522885A DK 522885 A DK522885 A DK 522885A DK 522885 A DK522885 A DK 522885A DK 522885 A DK522885 A DK 522885A DK 522885 A DK522885 A DK 522885A
Authority
DK
Denmark
Prior art keywords
cph2p
blocking agents
addrenge
scanable
beta
Prior art date
Application number
DK522885A
Other languages
English (en)
Other versions
DK168285B1 (da
DK522885D0 (da
Inventor
Nicholas Stephen Bodor
Original Assignee
Bodor Nicholas S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bodor Nicholas S filed Critical Bodor Nicholas S
Publication of DK522885A publication Critical patent/DK522885A/da
Publication of DK522885D0 publication Critical patent/DK522885D0/da
Application granted granted Critical
Publication of DK168285B1 publication Critical patent/DK168285B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
    • C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
    • C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Indole Compounds (AREA)
DK522885A 1984-03-14 1985-11-13 Skånsomme beta-adrenerge blokerende forbindelser og farmaceutisk acceptable syreadditionssalte deraf, samt et middel indeholdende sådanne forbindelser DK168285B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US58935984A 1984-03-14 1984-03-14
US58935984 1984-03-14
US8500322 1985-02-28
PCT/US1985/000322 WO1985004168A1 (en) 1984-03-14 1985-02-28 SOFT beta-ADRENERGIC BLOCKING AGENTS

Publications (3)

Publication Number Publication Date
DK522885A true DK522885A (da) 1985-11-13
DK522885D0 DK522885D0 (da) 1985-11-13
DK168285B1 DK168285B1 (da) 1994-03-07

Family

ID=24357687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK522885A DK168285B1 (da) 1984-03-14 1985-11-13 Skånsomme beta-adrenerge blokerende forbindelser og farmaceutisk acceptable syreadditionssalte deraf, samt et middel indeholdende sådanne forbindelser

Country Status (6)

Country Link
EP (1) EP0174956B1 (da)
JP (2) JPH08799B2 (da)
CA (1) CA1330992C (da)
DE (1) DE3579203D1 (da)
DK (1) DK168285B1 (da)
WO (1) WO1985004168A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579203D1 (de) * 1984-03-14 1990-09-20 Nicholas S Bodor Sanfte beta-adrenergische blockierende agenzien.
AU607437B2 (en) * 1986-09-02 1991-03-07 Du Pont Pharmaceuticals Company Resolution of dl-methyl 3-(4-(2-hydroxy-3-isopropylamino) propoxy)phenylpropionate((dl-esmolol))
US5268183A (en) * 1990-05-04 1993-12-07 Vidrio Plano De Mexico, S.A. Mold apparatus having an outwardly angled seal for encapsulating a glass sheet
WO1999001467A2 (en) * 1997-06-30 1999-01-14 Glaxo Group Limited Therapeutically active compounds with low systemic activity due to reduce half life

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8004087L (sv) * 1980-06-02 1981-12-03 Haessle Ab Nya parasubstituerade 3-fenoxi-1-alkylaminopropanol-2-er med betareceptorblockerande egenskaper, samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma, och metod att behandla akut ...
US4387103A (en) * 1980-11-28 1983-06-07 American Hospital Supply Corporation Method for treatment or prophylaxis of cardiac disorders
DE3579203D1 (de) * 1984-03-14 1990-09-20 Nicholas S Bodor Sanfte beta-adrenergische blockierende agenzien.

Also Published As

Publication number Publication date
CA1330992C (en) 1994-07-26
JPH07238017A (ja) 1995-09-12
DE3579203D1 (de) 1990-09-20
DK168285B1 (da) 1994-03-07
EP0174956B1 (en) 1990-08-16
JPH08799B2 (ja) 1996-01-10
JP2561034B2 (ja) 1996-12-04
DK522885D0 (da) 1985-11-13
EP0174956A1 (en) 1986-03-26
WO1985004168A1 (en) 1985-09-26
JPS61501448A (ja) 1986-07-17

Similar Documents

Publication Publication Date Title
DK335082A (da) Fremgangsmaade til behandling eller forebyggelse af hjertesygdomme
SE8404019L (sv) Oftalmiska antiinflammatoriska medel
PT84091B (pt) Processo para a preparacao de novos derivados da decahidroquinolina e de composicoes farmaceuticas que os contem
SE8504014D0 (sv) Aethylendiaminmonoamid-derivate
PT83992B (pt) Processo para a preparacao de tio-eteres assimetricos
DK522885A (da) Skaansomme beta-adrenerge blokerende midler
FR2409755A1 (fr) Medicaments a base de nouvelles indolo (2,3-a) quinolizidines
PT89082A (pt) Processo para a preparacao de novos derivados n-(23-vinblastinoilicos)do acido 1-amino-metilfosfonico
JPS5265254A (en) 2-(3-alkylamino propoxy)-diphenyl methanes
ES539160A0 (es) Un procedimiento para preparar derivados de penem
SE8200891L (sv) 2-amino-3-(halogenbensoyl)-metylfenylettiksyror samt estrar och salter derav
ES8302647A1 (es) Un procedimiento para la preparacion de guanidinas
FI870329A (fi) Foerfarande foer framstaellning av substituerade pyrrolidinoner.
FI841992A0 (fi) Substituerade isokinolinderivat.
ES8103047A1 (es) Procedimiento de preparacion de derivados aminoisoquinolinosasi como de sus sales de adicion acidas, farmaceuticamente aceptables y de sus derivados amonicos cuaternarios
ES8105291A1 (es) Procedimiento para la obtencion de derivados del decahidro- quinolinol
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
ES8702877A1 (es) Un metodo para producir un derivado de acido benzoico.
JPS5598158A (en) Novel alpha-methyl-3,4-dihydroxyphenylalanine derivative and its preparation
SE8003476L (sv) Isokinolinderivat

Legal Events

Date Code Title Description
PUP Patent expired